Search - tctmd.com

Displaying 681 - 700 of 836

Sort: Relevancy | Date

News Daily News

Un Stent Recubierto de una Malla resulta Seguro en Pacientes STEMI aunque el Riesgo de RLD, RVD es Mayor que con los SMD

July 08, 2014

News Daily News

Mesh-Covered Stent Safe in STEMI Patients but Risk of TLR, TVR Higher vs BMS

July 08, 2014

News Daily News

SCAAR: Menor Riesgo de Trombosis Precoz, Tardía del Stent con Nuevos SLF frente a SMD en el Manejo de Cuadros de STEMI

Yael L. Maxwell

July 03, 2014

News Daily News

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

Yael L. Maxwell

July 03, 2014

News Daily News

Un Estudio Pone de Manifiesto la Disparidad entre Resultados de Estudios Pre y Post-Comercialización sobre SLF

Caitlin E. Cox

June 13, 2014

News Daily News

Study Highlights Disparity Between Pre-, Postmarket Study Outcomes for DES

Caitlin E. Cox

June 13, 2014

News Daily News

Nationwide Registry Shows Trends in DES Use Over a Decade

June 02, 2014

News Daily News

Short-term DAPT After DES Decreases Bleeding with No Increase in Death, MI

May 20, 2014

News Daily News

La Terapia Antiplaquetaria Doble a Corto Plazo Post-Implantación de SLF Reduce las Hemorragias Sin un Aumento de Muerte ni IM

May 20, 2014

News Conference News EuroPCR 2014

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

Caitlin E. Cox

May 20, 2014

News Daily News

Cardiac Rehab Reduces Late Lumen Loss, Improves Risk Profile in Patients with Long Lesions

April 14, 2014

News Daily News

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

L.A. McKeown

April 11, 2014

News Conference News ACC 2014

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

Yael L. Maxwell

March 31, 2014

News Conference News ACC 2014

NEXT at 2 Years: Nobori DES Still Noninferior to Xience/Promus

Jason Kahn

March 31, 2014

Presentation Physiology and Intravascular Imaging 2014

Update on Neoatherosclerosis: A Novel Form of Stent Failure

Presenter: Ziad A. Ali

March 27, 2014

News Daily News

Las Mejoras en la Revascularización No Logran Reducir la Mortalidad por Todas las Causas en Japón

Caitlin E. Cox

March 20, 2014

News Daily News

Improvements in Revascularization Reduce Cardiac Death, MI and Repeat Revascularization, but not All-Cause Mortality in Japan

Caitlin E. Cox

March 20, 2014

News Daily News

Los Resultados SLF Varían según el Estado de la Diabetes y la Complejidad de la Lesión

Caitlin E. Cox

March 13, 2014

News Daily News

DES Outcomes Vary by Diabetes Status, Lesion Complexity

Caitlin E. Cox

March 13, 2014

News Daily News

Los SLF de 1ª Generación son Menos Rentables que SMD + Rapamicina Oral a los 5 Años

January 06, 2014

Advertisement

Un Stent Recubierto de una Malla resulta Seguro en Pacientes STEMI aunque el Riesgo de RLD, RVD es Mayor que con los SMD

Mesh-Covered Stent Safe in STEMI Patients but Risk of TLR, TVR Higher vs BMS

SCAAR: Menor Riesgo de Trombosis Precoz, Tardía del Stent con Nuevos SLF frente a SMD en el Manejo de Cuadros de STEMI

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

Un Estudio Pone de Manifiesto la Disparidad entre Resultados de Estudios Pre y Post-Comercialización sobre SLF

Study Highlights Disparity Between Pre-, Postmarket Study Outcomes for DES

Nationwide Registry Shows Trends in DES Use Over a Decade

Short-term DAPT After DES Decreases Bleeding with No Increase in Death, MI

La Terapia Antiplaquetaria Doble a Corto Plazo Post-Implantación de SLF Reduce las Hemorragias Sin un Aumento de Muerte ni IM

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

Cardiac Rehab Reduces Late Lumen Loss, Improves Risk Profile in Patients with Long Lesions

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates

NEXT at 2 Years: Nobori DES Still Noninferior to Xience/Promus

Update on Neoatherosclerosis: A Novel Form of Stent Failure

Las Mejoras en la Revascularización No Logran Reducir la Mortalidad por Todas las Causas en Japón

Improvements in Revascularization Reduce Cardiac Death, MI and Repeat Revascularization, but not All-Cause Mortality in Japan

Los Resultados SLF Varían según el Estado de la Diabetes y la Complejidad de la Lesión

DES Outcomes Vary by Diabetes Status, Lesion Complexity

Los SLF de 1ª Generación son Menos Rentables que SMD + Rapamicina Oral a los 5 Años

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content